Company
Roche
Official Name: Roche Holding AG
Headquarters: Basel, Switzerland
Employees: 100,920
CEO: Dr. Severin Schwan Ph.D.
Market Cap
CHF198.66 Billion
CHF as of Jan. 1, 2025
US$219.35 Billion
Company Description
Roche is a global healthcare company involved in prescription pharmaceuticals and diagnostics. It offers pharmaceutical products for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, and ophthalmology. It also provides in vitro diagnostics solutions for several indications, supplies diagnostic instruments, reagents, consumables, and test kits for research, and collaborates with other companies for drug development.
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
| Merck | $244.44 B |
| AstraZeneca | $214.55 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, the company supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. It has collaboration with Gilead Sciences, Inc. for COVID-19; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | CHF60.58 B |
| EBITDA | CHF18.66 B |
| Gross Profit TTM | CHF44.08 B |
| Profit Margin | 17.53% |
| Operating Margin | 35.27% |
| Quarterly Revenue Growth | 0.50% |
Stocks & Indices
Roche Holding AG has the following listings and related stock indices.
Stock: SIX: ROG wb_incandescent
Stock: OTC: RHHBF wb_incandescent
Stock: OTC: RHHBY wb_incandescent
Stock: BMV: ROGN wb_incandescent
Stock: SIX: RO wb_incandescent
Stock: FSX: RHO6 wb_incandescent
Stock: OTC: RHHVF wb_incandescent
Product & Services
Prescription pharmaceuticals, In vitro diagnostics, Oncology products, Neuroscience products, Infectious disease products, Immunology products, Cardiovascular and metabolism products, Ophthalmology products, Respiratory products, Research equipment and supplies